Literature DB >> 24758622

Clinical decisions. The guidelines battle on starting statins.

Ralph B D'Agostino, Benjamin J Ansell, Samia Mora, Harlan M Krumholz.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24758622     DOI： 10.1056/NEJMclde1314766

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  Lifestyle strategies for cardiovascular risk reduction.

Authors:  James M Rippe; Theodore J Angelopoulos
Journal:  Curr Atheroscler Rep       Date:  2014-10       Impact factor: 5.113

Review 2.  Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies.

Authors:  Richard Kones; Umme Rumana
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

Review 3.  A look at statin cost-effectiveness in view of the 2013 ACC/AHA cholesterol management guidelines.

Authors:  Roderick C Deaño; Ankur Pandya; Erica C Jones; William B Borden
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

4.  Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women.

Authors:  Jonathan V Todd; Stephen R Cole; David A Wohl; Ross J Simpson; Michele Jonsson Funk; M Alan Brookhart; Jennifer Cocohoba; Daniel Merenstein; Anjali Sharma; Jason Lazar; Joel Milam; Mardge Cohen; Stephen Gange; Tené T Lewis; Greer Burkholder; Adaora A Adimora
Journal:  AIDS Patient Care STDS       Date:  2017-11       Impact factor: 5.078

5.  Statin prescribing for primary prevention of cardiovascular disease: a cross-sectional, observational study.

Authors:  Kate Homer; Kambiz Boomla; Sally Hull; Isabel Dostal; Rohini Mathur; John Robson
Journal:  Br J Gen Pract       Date:  2015-08       Impact factor: 5.386

6.  PrEP Implementation Science: State-of-the-Art and Research Agenda.

Authors:  Carlos F Cáceres; Kenneth H Mayer; Rachel Baggaley; Kevin R O'Reilly
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

7.  Modelling total coronary heart disease burden and long-term benefit of cholesterol lowering in middle aged men with and without a history of cardiovascular disease.

Authors:  Chris J Packard; Robin Young; Kevin Ross; Ian Ford; Baishali M Ambegaonkar; Philippe Brudi; Colin McCowan
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2017-10-01

8.  The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention.

Authors:  Carlos F Cáceres; Florence Koechlin; Pedro Goicochea; Papa-Salif Sow; Kevin R O'Reilly; Kenneth H Mayer; Peter Godfrey-Faussett
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

9.  Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort.

Authors:  Charlotte Andersson; Danielle Enserro; Martin G Larson; Vanessa Xanthakis; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2015-04-17       Impact factor: 5.501

10.  Communicating statin evidence to support shared decision-making.

Authors:  Bruce Barrett; Jason Ricco; Margaret Wallace; David Kiefer; Dave Rakel
Journal:  BMC Fam Pract       Date:  2016-04-06       Impact factor: 2.497
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.